These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 1779255

  • 1. Antibacterial activity of ceftibuten, a new oral third generation cephalosporin.
    Debbia EA, Schito GC, Pesce A.
    J Chemother; 1991 Aug; 3(4):209-25. PubMed ID: 1779255
    [Abstract] [Full Text] [Related]

  • 2. [A comparative study of antibacterial activity of ceftibuten, ceftazidime, cefuroxime and ampicillin against clinical isolates].
    Ergova R, K'oleian E, Kharalambieva Ia, Mitov I, Docheva Iu.
    Vutr Boles; 2000 Aug; 32(1):13-7. PubMed ID: 11195191
    [Abstract] [Full Text] [Related]

  • 3. Microbiologic profile of ceftibuten, a new oral cephalosporin.
    Debbia EA, Pesce A, Chiesa M, Ricotta N, Schito GC.
    Drugs Exp Clin Res; 1992 Aug; 18(4):129-39. PubMed ID: 1451643
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.
    Jones RN, Barry AL.
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1576-82. PubMed ID: 3190185
    [Abstract] [Full Text] [Related]

  • 5. Ceftibuten: a review of antimicrobial activity, spectrum and other microbiologic features.
    Jones RN.
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S77-83. PubMed ID: 7567314
    [Abstract] [Full Text] [Related]

  • 6. Cefditoren in vitro activity and spectrum: a review of international studies using reference methods.
    Jones RN, Pfaller MA, Jacobs MR, Appelbaum PC, Fuchs PC.
    Diagn Microbiol Infect Dis; 2001 Jul; 41(1-2):1-14. PubMed ID: 11687308
    [Abstract] [Full Text] [Related]

  • 7. In vitro studies with Bay V 3522, a new oral cephalosporin.
    Thomson KS, Sanders CC, Sanders WE.
    Drugs Exp Clin Res; 1991 Jul; 17(3):165-73. PubMed ID: 1914843
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial activity and spectrum of ceftibuten (7432-S, SCH 39720)--a review of United States and Canadian results.
    Jones RN.
    Diagn Microbiol Infect Dis; 1991 Jul; 14(1):37-43. PubMed ID: 2013209
    [Abstract] [Full Text] [Related]

  • 9. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitro.
    Bauernfeind A, Jungwirth R, Eberlein E, Klesel N, Adam F, Isert D, Limbert M, Markus A, Schrinner E, Seibert G.
    J Antibiot (Tokyo); 1992 Apr; 45(4):505-20. PubMed ID: 1592683
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin.
    Briggs BM, Jones RN, Erwin ME, Barrett MS, Johnson DM.
    Diagn Microbiol Infect Dis; 1991 Apr; 14(5):425-34. PubMed ID: 1797457
    [Abstract] [Full Text] [Related]

  • 11. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
    Bauernfeind A, Jungwirth R.
    Infection; 1991 Apr; 19(5):353-62. PubMed ID: 1800377
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M, Browne FA, Jacobs MR, Appelbaum PC.
    Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
    [Abstract] [Full Text] [Related]

  • 14. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
    Bauernfeind A.
    Diagn Microbiol Infect Dis; 1991 Jan; 14(1):63-74. PubMed ID: 2013211
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro activity of ceftibuten against Haemophilus influenzae and Branhamella catarhallis.
    Doern GV.
    Diagn Microbiol Infect Dis; 1991 Jan; 14(1):75-7. PubMed ID: 1901536
    [Abstract] [Full Text] [Related]

  • 17. Review of the in vitro antibacterial activity of cefprozil, a new oral cephalosporin.
    Thornsberry C.
    Clin Infect Dis; 1992 Jun; 14 Suppl 2():S189-94; discussion S195-6. PubMed ID: 1617037
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.